| abstract |
Provided is a heterocyclic compound useful for treating a disorder selected from the group consisting of cancer, eye disease, inflammation, psoriasis, and viral infection. A compound having the structure of the following formula (A). (In formula (A), R1 is a substituent selected from the group consisting of aryl, substituted aryl, heterocycle, heteroaryl, substituted heteroaryl, and substituted heteroaryl; R2 is hydrogen, hydroxyl, C1- A substituent selected from the group consisting of C6 alkyl, C1-C6 alkylamino, halogen, C1-C6 alkoxy, -NO2, -NH2, and -C≡N; and R3 is aryl, substituted aryl, heterocyclic , Heteroaryl, substituted heterocycle, and substituted heteroaryl. In addition to compounds of formula (A), heterocyclic compounds derived from triazines, triazoles and oxadiazoles are also disclosed. [Selection figure] None |